“Original antigenic sin”: A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants
Maryam Noori, Seyed Aria Nejadghaderi, Nima Rezaei
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
Topics & Concepts
Booster (rocketry)VirologyVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Antigen2019-20 coronavirus outbreakBiologyMedicineImmunologyInfectious disease (medical specialty)EngineeringOutbreakDiseaseAerospace engineeringPathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies